NTRK3 and malignant colon neoplasm: Solomon et al.11 showed a sensitivity of 87.5% (7/8) and a specificity of 100% (24/24) for colon cancer, and the cause of the lower sensitivity is the false negative for NTRK3 fusion tumor11.